Startup profile

Dandelion Health

Series ANew York, NY, United States$14M raised

Open roles0
Total raised$14M
Team size1-10
Founded · Stage2020 · Series A

We pull jobs from sources most job seekers never check

Email icon

Get Real-Time Job Alerts For Free

Jobs updated every minute. Get notified for free when new roles matching your interests go live.

No categories available

About the company

What they build and who they serve.

Dandelion Health is a clinical intelligence platform for life sciences that combines structured electronic medical records and claims data with unstructured clinical text and raw biological signals — including ECG waveforms, echocardiogram videos, radiology imaging, ultrasound, and pulmonary tests — across a network of 73 hospitals and more than 15 million patients. Its multimodal AI platform supports pharmaceutical partners through trial design optimization, biomarker discovery, real-world evidence generation, and AI algorithm validation. The company is headquartered in New York and serves leading global pharma companies and the American Heart Association.

Why it matters

Signals from funding, traction, and product direction.

  • Network spans 73 hospitals and more than 15 million patients, with over 8 petabytes of multimodal data combining structured EMR/claims with raw biological signals (ECGs, echocardiograms, radiology imaging, ultrasound, pulmonary function tests).
  • In a trial emulation with a top-10 pharmaceutical company, the multimodal approach delivered projected cost savings of up to $84M and accelerated timelines by up to 11 months versus conventional trial design.
  • Existing investors Primary Venture Partners, Moxxie Ventures and Convergent Ventures all returned for the round; Healthier Capital (founded by former One Medical CEO Amir Dan Rubin) and Colle Capital are new investors.
  • Founding team: CEO Elliott Green; CSO Ziad Obermeyer (Harvard Medical School / UC Berkeley); Sendhil Mullainathan (MIT economist, MacArthur Fellow); and Niyum Gandhi (CFO/CSO of Mass General Brigham). Existing partners include leading global pharma companies and the American Heart Association.

Funding history

Rounds and investors over time, newest first.

  1. Series A

    $14M
    Primary Venture PartnersHealthier Capital · LeadColle CapitalMoxxie VenturesConvergent Ventures

In the news

Press, announcements, and coverage about this company.

Investors

Primary Venture PartnersHealthier CapitalColle CapitalMoxxie VenturesConvergent Ventures

Focus areas

Series AAI/MLClinical TrialsEnterprise SoftwareHealthtech
Email alerts

Don’t get beat to tomorrow’s openings

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.

👉 Get free daily job posts